ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES

Formulations comprising an anti-integrin beta7 antibody or an antigen-binding fragment thereof are provided, including pharmaceutical formulations. Also provided are article of manufactures comprising such formulations, and methods of using such formulations. L'invention concerne des formulatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AMARCHINTA, HEMANTH, ABOUHOSSEIN, MARIAM, RAVANELLO, RENATO, ZHANG, WENHUI, TANG, MEINA TAO, BORUVKA, AUDREY, FLORES, HEATHER L, PULLEY, JENNIFER, DING, HAN TING, TYRRELL, HELEN, GIESE, GLEN SCOTT, TOLE, SWATI
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AMARCHINTA, HEMANTH
ABOUHOSSEIN, MARIAM
RAVANELLO, RENATO
ZHANG, WENHUI
TANG, MEINA TAO
BORUVKA, AUDREY
FLORES, HEATHER L
PULLEY, JENNIFER
DING, HAN TING
TYRRELL, HELEN
GIESE, GLEN SCOTT
TOLE, SWATI
description Formulations comprising an anti-integrin beta7 antibody or an antigen-binding fragment thereof are provided, including pharmaceutical formulations. Also provided are article of manufactures comprising such formulations, and methods of using such formulations. L'invention concerne des formulations comprenant un anticorps anti-intégrine bêta7 ou un fragment de liaison à l'antigène associé, notamment des formulations pharmaceutiques. L'invention concerne également un article manufacturé comprenant de telles formulations, et des méthodes d'utilisation de telles formulations.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3190109A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3190109A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3190109A13</originalsourceid><addsrcrecordid>eNrjZDB19Avx1PX0C3F1D_L0U3ByDXE0VwCJOfm7RCq4-Qf5hvo4hnj6-wUDRV0UXFzDPJ1dg3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo7GhpYGhgaWjoTERSgCZbicP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES</title><source>esp@cenet</source><creator>AMARCHINTA, HEMANTH ; ABOUHOSSEIN, MARIAM ; RAVANELLO, RENATO ; ZHANG, WENHUI ; TANG, MEINA TAO ; BORUVKA, AUDREY ; FLORES, HEATHER L ; PULLEY, JENNIFER ; DING, HAN TING ; TYRRELL, HELEN ; GIESE, GLEN SCOTT ; TOLE, SWATI</creator><creatorcontrib>AMARCHINTA, HEMANTH ; ABOUHOSSEIN, MARIAM ; RAVANELLO, RENATO ; ZHANG, WENHUI ; TANG, MEINA TAO ; BORUVKA, AUDREY ; FLORES, HEATHER L ; PULLEY, JENNIFER ; DING, HAN TING ; TYRRELL, HELEN ; GIESE, GLEN SCOTT ; TOLE, SWATI</creatorcontrib><description>Formulations comprising an anti-integrin beta7 antibody or an antigen-binding fragment thereof are provided, including pharmaceutical formulations. Also provided are article of manufactures comprising such formulations, and methods of using such formulations. L'invention concerne des formulations comprenant un anticorps anti-intégrine bêta7 ou un fragment de liaison à l'antigène associé, notamment des formulations pharmaceutiques. L'invention concerne également un article manufacturé comprenant de telles formulations, et des méthodes d'utilisation de telles formulations.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220203&amp;DB=EPODOC&amp;CC=CA&amp;NR=3190109A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220203&amp;DB=EPODOC&amp;CC=CA&amp;NR=3190109A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AMARCHINTA, HEMANTH</creatorcontrib><creatorcontrib>ABOUHOSSEIN, MARIAM</creatorcontrib><creatorcontrib>RAVANELLO, RENATO</creatorcontrib><creatorcontrib>ZHANG, WENHUI</creatorcontrib><creatorcontrib>TANG, MEINA TAO</creatorcontrib><creatorcontrib>BORUVKA, AUDREY</creatorcontrib><creatorcontrib>FLORES, HEATHER L</creatorcontrib><creatorcontrib>PULLEY, JENNIFER</creatorcontrib><creatorcontrib>DING, HAN TING</creatorcontrib><creatorcontrib>TYRRELL, HELEN</creatorcontrib><creatorcontrib>GIESE, GLEN SCOTT</creatorcontrib><creatorcontrib>TOLE, SWATI</creatorcontrib><title>ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES</title><description>Formulations comprising an anti-integrin beta7 antibody or an antigen-binding fragment thereof are provided, including pharmaceutical formulations. Also provided are article of manufactures comprising such formulations, and methods of using such formulations. L'invention concerne des formulations comprenant un anticorps anti-intégrine bêta7 ou un fragment de liaison à l'antigène associé, notamment des formulations pharmaceutiques. L'invention concerne également un article manufacturé comprenant de telles formulations, et des méthodes d'utilisation de telles formulations.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB19Avx1PX0C3F1D_L0U3ByDXE0VwCJOfm7RCq4-Qf5hvo4hnj6-wUDRV0UXFzDPJ1dg3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo7GhpYGhgaWjoTERSgCZbicP</recordid><startdate>20220203</startdate><enddate>20220203</enddate><creator>AMARCHINTA, HEMANTH</creator><creator>ABOUHOSSEIN, MARIAM</creator><creator>RAVANELLO, RENATO</creator><creator>ZHANG, WENHUI</creator><creator>TANG, MEINA TAO</creator><creator>BORUVKA, AUDREY</creator><creator>FLORES, HEATHER L</creator><creator>PULLEY, JENNIFER</creator><creator>DING, HAN TING</creator><creator>TYRRELL, HELEN</creator><creator>GIESE, GLEN SCOTT</creator><creator>TOLE, SWATI</creator><scope>EVB</scope></search><sort><creationdate>20220203</creationdate><title>ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES</title><author>AMARCHINTA, HEMANTH ; ABOUHOSSEIN, MARIAM ; RAVANELLO, RENATO ; ZHANG, WENHUI ; TANG, MEINA TAO ; BORUVKA, AUDREY ; FLORES, HEATHER L ; PULLEY, JENNIFER ; DING, HAN TING ; TYRRELL, HELEN ; GIESE, GLEN SCOTT ; TOLE, SWATI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3190109A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>AMARCHINTA, HEMANTH</creatorcontrib><creatorcontrib>ABOUHOSSEIN, MARIAM</creatorcontrib><creatorcontrib>RAVANELLO, RENATO</creatorcontrib><creatorcontrib>ZHANG, WENHUI</creatorcontrib><creatorcontrib>TANG, MEINA TAO</creatorcontrib><creatorcontrib>BORUVKA, AUDREY</creatorcontrib><creatorcontrib>FLORES, HEATHER L</creatorcontrib><creatorcontrib>PULLEY, JENNIFER</creatorcontrib><creatorcontrib>DING, HAN TING</creatorcontrib><creatorcontrib>TYRRELL, HELEN</creatorcontrib><creatorcontrib>GIESE, GLEN SCOTT</creatorcontrib><creatorcontrib>TOLE, SWATI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AMARCHINTA, HEMANTH</au><au>ABOUHOSSEIN, MARIAM</au><au>RAVANELLO, RENATO</au><au>ZHANG, WENHUI</au><au>TANG, MEINA TAO</au><au>BORUVKA, AUDREY</au><au>FLORES, HEATHER L</au><au>PULLEY, JENNIFER</au><au>DING, HAN TING</au><au>TYRRELL, HELEN</au><au>GIESE, GLEN SCOTT</au><au>TOLE, SWATI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES</title><date>2022-02-03</date><risdate>2022</risdate><abstract>Formulations comprising an anti-integrin beta7 antibody or an antigen-binding fragment thereof are provided, including pharmaceutical formulations. Also provided are article of manufactures comprising such formulations, and methods of using such formulations. L'invention concerne des formulations comprenant un anticorps anti-intégrine bêta7 ou un fragment de liaison à l'antigène associé, notamment des formulations pharmaceutiques. L'invention concerne également un article manufacturé comprenant de telles formulations, et des méthodes d'utilisation de telles formulations.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3190109A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AMARCHINTA,%20HEMANTH&rft.date=2022-02-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3190109A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true